Clinical Trial Update: Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 study of pracinostat with azacitidine in previously untreated myelodysplastic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Pracinostat (pracinostat)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED